{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:17:41Z","timestamp":1788322661370,"version":"build-2803163510"},"reference-count":30,"publisher":"Impact Journals, LLC","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,4,19]]},"DOI":"10.18632\/oncotarget.8307","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T01:31:41Z","timestamp":1458783101000},"page":"21181-21189","source":"Crossref","is-referenced-by-count":45,"title":["Evaluation of p16\/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China"],"prefix":"10.18632","volume":"7","author":[{"given":"Lu-Lu","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qin","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Ni","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Jing","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Feng","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Kai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Henan Office for Cancer Control and Research, Zhengzhou, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qin","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Lin","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,23]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1470-2045(05)01761-4","article-title":"China's plans to curb cervical cancer","volume":"6","author":"Wen","year":"2005","journal-title":"Lancet Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/LGT.0b013e318285423c","article-title":"Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines","volume":"17","author":"Kinney","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"3","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1470-2045(10)70256-4","article-title":"Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China","volume":"11","author":"Castle","year":"2010","journal-title":"Lancet Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Iftner","year":"2006","journal-title":"Int J Cancer"},{"key":"5","first-page":"642","article-title":"Human papillomavirus DNApapanicolaou screening tests for cervical cancer","volume":"358","author":"Fields","year":"2008","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1309\/BA43HMCAJ26VWQH3","article-title":"Interlaboratory reliability of Hybrid Capture 2","volume":"122","author":"Peyton","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1309\/84E5WHJQHK83BGQD","article-title":"Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting","volume":"124","author":"Ronco","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Iftner","year":"2008","journal-title":"Bmj"},{"key":"9","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.2011.38.8389","article-title":"Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up","volume":"30","author":"Wacholder","year":"2012","journal-title":"J Clin Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","article-title":"Biomarkers in cervical cancer screening","volume":"23","author":"von Knebel","year":"2007","journal-title":"Dis Markers"},{"key":"11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.28485","article-title":"p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China","volume":"134","author":"Qiao","year":"2014","journal-title":"Int J Cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3802\/jgo.2008.19.3.162","article-title":"Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection","volume":"19","author":"Kim","year":"2008","journal-title":"J Gynecol Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/jnci\/djt235","article-title":"Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study","volume":"105","author":"Rehm","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1471-0528.13076","article-title":"A systematic review of p16\/Ki-67 immuno-testing for triage of low grade cervical cytology","volume":"122","author":"Zechmeister-Koss","year":"2015","journal-title":"Bjog"},{"key":"15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 Dual-stained cytology","volume":"121","author":"Ridder","year":"2011","journal-title":"Gynecol Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population","volume":"18","author":"Schiffman","year":"2012","journal-title":"Clin Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2012.05.004","article-title":"p16\/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy","volume":"126","author":"Benevolo","year":"2012","journal-title":"Gynecol Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0959-8049(02)00462-8","article-title":"New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections","volume":"38","author":"von Knebel","year":"2002","journal-title":"Eur J Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-009-0412-8","article-title":"The biological properties of E6 and E7 oncoproteins from human papillomaviruses","volume":"40","author":"Tommasino","year":"2010","journal-title":"Virus Genes"},{"key":"20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Solomon","year":"2009","journal-title":"Obstet Gynecol"},{"key":"21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"Skegg","year":"2008","journal-title":"Lancet Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ygyno.2014.03.008","article-title":"Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China","volume":"133","author":"Qiao","year":"2014","journal-title":"Gynecol Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000367838","article-title":"Predictive value of the combined p16 and Ki-67 immunocytochemistry in low-grade squamous intraepithelial lesions","volume":"58","author":"Griesser","year":"2014","journal-title":"Acta Cytol"},{"key":"24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cncy.21542","article-title":"Prospective evaluation of p16\/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results","volume":"123","author":"Ridder","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/dc.22900","article-title":"CINtec(R) PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion","volume":"41","author":"Bose","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.20140","article-title":"p16\/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study","volume":"119","author":"Ridder","year":"2011","journal-title":"Cancer Cytopathol"},{"key":"27","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/ijc.29290","article-title":"Triaging HPV-positive women with normal cytology by p16\/Ki-67 dual-stained cytology testing: baseline and longitudinal data","volume":"136","author":"Meijer","year":"2015","journal-title":"Int J Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/cncy.21473","article-title":"Interobserver reproducibility and accuracy of p16\/Ki-67 dual-stain cytology in cervical cancer screening","volume":"122","author":"Kinney","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/cncy.21511","article-title":"Interpretation of p16(INK4a) \/Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology","volume":"123","author":"Ghiringhello","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/bjc.2014.34","article-title":"Triaging borderline\/mild dyskaryotic Pap cytology with p16\/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study","volume":"110","author":"Meijer","year":"2014","journal-title":"Br J Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T19:47:28Z","timestamp":1589226448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,23]]},"references-count":30,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,4,19]]}},"alternative-id":["8307","27029033"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8307","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,23]]}}}